Vor Biopharma Statistics
Total Valuation
Vor Biopharma has a market cap or net worth of $90.99 million. The enterprise value is $33.90 million.
Important Dates
The last earnings date was Thursday, March 20, 2025, after market close.
Earnings Date | Mar 20, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Vor Biopharma has 124.85 million shares outstanding. The number of shares has increased by 2.25% in one year.
Current Share Class | 124.85M |
Shares Outstanding | 124.85M |
Shares Change (YoY) | +2.25% |
Shares Change (QoQ) | +2.28% |
Owned by Insiders (%) | 31.91% |
Owned by Institutions (%) | 12.20% |
Float | 39.01M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.97 |
P/TBV Ratio | 0.97 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.19, with a Debt / Equity ratio of 0.33.
Current Ratio | 5.19 |
Quick Ratio | 4.94 |
Debt / Equity | 0.33 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -94.52% and return on invested capital (ROIC) is -48.11%.
Return on Equity (ROE) | -94.52% |
Return on Assets (ROA) | -44.42% |
Return on Invested Capital (ROIC) | -48.11% |
Return on Capital Employed (ROCE) | -97.51% |
Revenue Per Employee | n/a |
Profits Per Employee | -$735,308 |
Employee Count | 159 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.93% in the last 52 weeks. The beta is -0.41, so Vor Biopharma's price volatility has been lower than the market average.
Beta (5Y) | -0.41 |
52-Week Price Change | -65.93% |
50-Day Moving Average | 1.16 |
200-Day Moving Average | 0.99 |
Relative Strength Index (RSI) | 30.48 |
Average Volume (20 Days) | 291,685 |
Short Selling Information
The latest short interest is 1.33 million, so 1.06% of the outstanding shares have been sold short.
Short Interest | 1.33M |
Short Previous Month | 1.45M |
Short % of Shares Out | 1.06% |
Short % of Float | 3.41% |
Short Ratio (days to cover) | 3.72 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -121.19M |
Pretax Income | -118.09M |
Net Income | -116.91M |
EBITDA | -117.66M |
EBIT | -121.19M |
Earnings Per Share (EPS) | -$1.70 |
Full Income Statement Balance Sheet
The company has $91.93 million in cash and $31.83 million in debt, giving a net cash position of $60.10 million or $0.48 per share.
Cash & Cash Equivalents | 91.93M |
Total Debt | 31.83M |
Net Cash | 60.10M |
Net Cash Per Share | $0.48 |
Equity (Book Value) | 96.66M |
Book Value Per Share | 0.77 |
Working Capital | 77.90M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$99.66 million and capital expenditures -$229,000, giving a free cash flow of -$99.89 million.
Operating Cash Flow | -99.66M |
Capital Expenditures | -229,000 |
Free Cash Flow | -99.89M |
FCF Per Share | -$0.80 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Vor Biopharma does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.25% |
Shareholder Yield | -2.25% |
Earnings Yield | -124.38% |
FCF Yield | -106.26% |
Analyst Forecast
The average price target for Vor Biopharma is $9.43, which is 1,193.91% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $9.43 |
Price Target Difference | 1,193.91% |
Analyst Consensus | Strong Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |